Bausch Health Companies (BHC) EBIT Margin (2009 - 2026)

Bausch Health Companies has disclosed EBIT Margin across 18 years of filings, most recently posting 37.64% for Q1 2026.

• EBIT Margin for Q1 2026 came in at 37.64%, down 4986.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.57% (down 1026.0% YoY), and the FY2025 annual result was 17.66%, up 160.0% from the prior year.
• EBIT Margin came in at 37.64% for Q1 2026 at Bausch Health Companies, down from 16.95% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 23.09% in Q3 2025 to a low of 37.64% in Q1 2026.
• The 5-year median for EBIT Margin is 13.05% (2024), against an average of 9.63%.
• Across the five-year window, EBIT Margin jumped 2579 bps in 2023 and plunged 4986 bps in 2026, its largest moves.
• Bausch Health Companies' EBIT Margin stood at 10.76% in 2022, then jumped by 240 bps to 15.03% in 2023, then soared by 45 bps to 21.81% in 2024, then fell by 22 bps to 16.95% in 2025, then plunged by 322 bps to 37.64% in 2026.
• The last three EBIT Margin figures came in at 37.64% (Q1 2026), 16.95% (Q4 2025), and 23.09% (Q3 2025), per Business Quant data.